Back to search
Solid Tumors, KRAS Mutation; SOS1
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Solid Tumors, KRAS Mutation; SOS1 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Solid Tumors, KRAS Mutation; SOS1 trials you may qualify forThis is a Phase 1, open-label, multicenter, study evaluating the safety, tolerability, PK, PD, and anti-tumor activity of MRTX0902 alone and in combination with…
This is a study in adults with advanced cancer (solid tumours) in whom previous chemotherapy was not successful. Only people who have a tumour with a KRAS mutat…